Sally Bennett

Sally Bennett

Director/Board Member at INNATE PHARMA

Net worth: 3 981 $ as of 30/09/2026

54 year
Finance
Commercial Services
Health Technology

Profile

Sally Bennett is currently Director at Mosaic Therapeutics Ltd. and P4 Precision Medicine Accelerator.
The current roles also include Independent Member-Supervisory Board at Innate Pharma SA since 2022, Member at The Institute of Directors, and Member-Governors Council at University College London Hospitals NHS Foundation Trust.
Former roles include Independent Non-Executive Director at Oncoinvent ASA, Analyst at ING Bank NV (United Kingdom), Senior Member at HealthCor Management LP, Senior Research Analyst at Piper Sandler Ltd. from 2006 to 2007, and Analyst at Healthcor Management UK LLP from 2008 to 2014.
Education includes undergraduate and doctorate degrees from The University of Manchester.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2026 2,500 ( 0% ) 3 981 $ 30/09/2026

Sally Bennett active positions

CompaniesPositionStart
INNATE PHARMA Director/Board Member 20/05/2022
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -

Former positions of Sally Bennett

CompaniesPositionEnd
Analyst-Equity 02/07/2014
Analyst-Equity 30/04/2007
Corporate Officer/Principal -
ONCOINVENT ASA Director/Board Member -
░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ -
See the detail of Sally Bennett's experience

Education of Sally Bennett

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Health Technology

Health Services

Commercial Services

Commercial Services